Cypress Capital Management (Wyoming)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-14,654
Closed -$1.38M 300
2019
Q1
$1.38M Sell
14,654
-200
-1% -$17.5K 1.85% 15
2018
Q4
$952K Sell
14,854
-3,890
-21% -$287K 1.83% 12
2018
Q3
$1.68M Sell
18,744
-1,200
-6% -$106K 1.69% 14
2018
Q2
$1.58M Sell
19,944
-9,787
-33% -$813K 1.66% 15
2018
Q1
$2.65M Sell
29,731
-19,160
-39% -$1.84M 3.04% 6
2017
Q4
$5.1M Sell
48,891
-1,845
-4% -$208K 5.78% 3
2017
Q3
$7.4M Hold
50,736
8.75% 2
2017
Q2
$6.59M Buy
50,736
+1,030
+2% +$126K 7.55% 2
2017
Q1
$6.18M Sell
49,706
-12,460
-20% -$1.49M 7.65% 2
2016
Q4
$7.32M Buy
62,166
+505
+0.8% +$56.2K 7.71% 3
2016
Q3
$6.45M Buy
61,661
+4,080
+7% +$442K 8.24% 2
2016
Q2
$5.68M Buy
57,581
+2,080
+4% +$215K 7.43% 3
2016
Q1
$5.56M Buy
55,501
+2,465
+5% +$254K 7.49% 2
2015
Q4
$6.35M Hold
53,036
7.99% 2
2015
Q3
$5.74M Sell
53,036
-1,080
-2% -$134K 7.37% 2
2015
Q2
$6.26M Buy
54,116
+1,950
+4% +$223K 7.08% 2
2015
Q1
$6.01M Buy
52,166
+300
+0.6% +$35.8K 7.36% 2
2014
Q4
$5.8M Buy
+51,866
New +$5.47M 7.54% 2

Other funds holding CELG

Cypress Capital Management (Wyoming)'s CELG Position: Q2 2019 in Review

Cypress Capital Management (Wyoming) sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 14,654 shares — an estimated $1.38M sold.

Cypress Capital Management (Wyoming) first reported a position in CELG in Q4 2014 and held it in 18 quarters. The position peaked at $7.4M in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Cypress Capital Management (Wyoming) reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 14,654 Celgene Corp shares in Q2 2019, an estimated $1.38M.
  • Cypress Capital Management (Wyoming) first reported a position in Celgene Corp in Q4 2014 and held it in 18 quarters.
  • Cypress Capital Management (Wyoming)'s Celgene Corp position peaked at $7.4M in Q3 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2019, filed 12 Aug 2019.